Skip to main content
. 2019 Feb 21;17(4):3247–3254. doi: 10.3892/etm.2019.7290

Figure 3.

Figure 3.

TLR9 mRNA levels remained high in the poor prognosis group in the 2 years following diagnosis of systemic lupus erythematosus. Expression of TLR9 mRNA at the beginning of the study (baseline) and 2 years following diagnosis were compared in the favorable prognosis group (n=20) and poor prognosis group (n=10). There was a significant difference in the expression of TLR9 mRNA between the favorable prognosis and poor prognosis groups at baseline (P<0.0001). The expression of TLR9 mRNA decreased significantly 2 years following diagnosis (P<0.0001) in the favorable prognosis group compared with the level at baseline but remained high in the poor prognosis group (P=0.1192). Data are expressed as the mean ± standard deviation. TLR9, toll-like receptor 9.